Along with other Novartis divisions we are the leading supplier of medicines on the Slovene market with clear plans for further development.
Read key business and development news in our company and various activities that we support and co-create. You can also browse the news archives dating back to 1998, our photo library and visual identity. For additional information, you can write to us at info.lek@sandoz.com.
With welcome addresses by Robert Ljoljo, President of the Board of Management of Lek and Novartis Country President Slovenia, and Prof. Dr. Igor Papič, Rector ...
Lek, which is part of Novartis, is this year once again among the recipients of the highest regional awards for innovative achievements, awarded by the ...
At the 39th International Conference on the Development of Organizational Sciences, Novartis in Slovenia received the best HR practice – honorable mention award for outstanding ...
Novartis today announced the pricing of a EUR 1.85 billion sustainability-linked bond (SLB), reinforcing its commitment to ESG principles and the 2025 Patient Access Targets ...
Contact
Lek d.d.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
info.lek@sandoz.com
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR
Ask us
Katarina Klemenc
T: +386 1 580 22 43
F: +386 1 580 24 32
info.lek@sandoz.com